Ex vivo gene therapy for älzheimer's disease and spinal cord injury

Clinical Neuroscience

Volumn 3, Issue 5, 1995, Pages 268-274

  Blesch, Armin ^a   Tuszynski, Nark ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fibroblasts; NGF; Primate; Regeneration; Retroviral vector

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR;

ALZHEIMER DISEASE; CELL TRANSPLANTATION; CHOLINERGIC NERVE CELL; FIBROBLAST; FOREBRAIN; GENE TRANSFER; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RETROVIRUS; REVIEW; SPINAL CORD INJURY; TRANSGENE;

ALZHEIMER DISEASE; ANIMALS; FIBROBLASTS; GENE THERAPY; GENETIC VECTORS; HUMANS; NERVE GROWTH FACTORS; RETROVIRIDAE; SPINAL CORD INJURIES;

EID: 0029548385     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Arenas E, Persson H (1994): Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature 367:368-371.
2. Aubert I, Ridet J-L, Gage FH (1995): Regeneration in the adult mammalian CNS: Guided by development. Curr Opin Neurobiol 5:625-635.
3. Bahr M, Bonhoeffer F (1994): Perspectives on axonal regeneration in the mammalian CNS. TINS 17:473-479.
4. Barba D, Hardin J, Ray J, Gage FH (1993): Thymidine kinase-mediated killing of rat brain tumors. J Neurosurg 79:729735.
5. Bartus R, Dean RL, Beer C, Lippa AS (1982): The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408417.
6. Bregman BS, Kunkel-Badgen E, Reier PJ, Dai HN, McAtee M, Gao D (1993): Recovery of function after spinal cord injury: Mechanisms underlying transplant-mediated recovery of function differ after spinal cord injury in newborn and adult rats. Exp Neurol 123:316.
7. Bregman BS, Kunkel-Bagden E, Schnell L, Dai Hn, Gao D, Schwab ME (1995): Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 378:498-501.
8. Chen KS, Gage FH (1995): Somatic gene transfer of NGF to the aged brain: Behavioral and morphological amelioration. J Neurosci 15:2819-2825.
9. Coyle JT, Price PH, Delong MR (1983): Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 219: 1184-1189.
10. David S, Aguayo A (1981): Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science 214:931-933.
11. Emerich DF, Winn SR, Harper J, Hammang JP, Baetge EE, Kordower JH (1994): Implants of polymer encapsulated human NGF-secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol 349:148164.
12. Fisher LJ, Schinstine M, Salvaterra P, Dekker AJ, Thai L, Gage FH (1993): In vivo production and release of acteylcholine from primary fibroblats genetically modified to express choline-acetyltransferase. J Neurochem 61:1323-1332.
13. Gage FH, Wictorin K, Ficher W, Williams LR, Varon S, Bjorklund A (1986): Life and death of cholinergic neurons in the septal and diagonal band region after fimbria-fornix transsection. Neuroscience 19:241-255.
14. Gage FH, Wolff JA, Rosenberg MB, Xu L, Yee JE, Shults C, Friedman T (1987): Grafting genetically modified cells to the brain: Possibilities for the future. Neuroscience 23:795-807.
15. Gage FH, Armstrong DM, Williams LR, Varon S (1988): Morphologic response of axotomized septal neurons to nerve growth factor. J Comp Neurol 269:147155.
16. Geula C, Mesulam M-M (1994): Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. In Terry RD, Katzmann R, Bick KL (eds): Alzheimer Disease. New York: Raven Press, pp 263-291.
17. Gossen M, Bonin AL, Bujard H (1993): Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. TIBS 18:471-475.
18. Hefti F (1986): Nerve growth factor (NGF) promotes survival of septal cholinergic neurons after fimbrial transsection. J Neurosci 6:2155-2162.
19. Horellou P, Brundin P, Kaien P, Mallet J, Bjorklund A (1990): In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5:393-402.
20. Hone H, Bando Y, Chi H, Takenaka T (1991): NGF enhances neurite regeneration from nerve transsected terminals of young adult and aged mouse dorsal root ganglia in vitro. Neurosci Lett 121:125-128.
21. Kang UJ, Fisher LJ, O'Malley KL, Gage FH (1993): Regulation of dopamine production by genetically modified primary fibroblasts. J Neurosci 13:5203-5211.
22. Kawaja MD, Rosenberg MB, Yoshida K, Gage FH (1992): Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J. Neurosci 12:2849-2864.
23. Koliatsos VE, Nauta HJW, Clatterbuck RE, Holtzman DM, Mobley WC, Price DL (1990): Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J Neurosci 10:3801-3813.
24. Koliatsos VE, Crawford TO, Price DL (1991): Axotomy induces nerve growth factor receptor immunoreactivity in spinal motor neurons. Brain Res 549:297-304.
25. Kordower JH, Fiandaca MS (1990): Response of the monkey cholinergic septohippocampal system to fornix transsection: A histochemical and cytochemical analysis. J Comp Neurol 298:443-457.
26. Kordower JH, Winn SR, Liu Y-T, Mufson EJ, Sladek JR, Hammang JP, Baetge EE, Emerich DF (1994): The aged monkey basal forebrain: Rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA 91:10898-10902.
27. Kromer LF (1987): Nerve growth factor treatment after brain injury prevents neuronal death. Science 235:214-216.
28. Levi-Montalcini R (1987): The nerve growth factor 35 years later. Science 237:11541162.
29. Lucidi-Phillipi CA, Gage FH, Shults CW, Jones KR, Reichardt LF, Kang UJ (1995): Brain-derived neurotrophic factor-transduced fibroblasts: Production of BDNF and effects of grafting to the adult rat brain. J Comp Neurol 354:361-376.
30. Marchand R, Woerly S (1990): Transsected spinal cords grafted with in-situ self assembled collagen matrices. Neuroscience 36:45-60.
31. Masliah E, Terry RD, Alford M, DeTersa R, Hansen LA (1991): Cortical and subcortical patterns of synaptophysin like immunoreactivity in Alzheimer's disease. Am J Pathol 138:235-246.
32. Miller AD, Miller DG, Garcia JV, Lynch CM (1993): Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217:581-599.
33. Perry EK, Yomlinson BE, Blessed G, Bergman K, Gibson PH, Perry RH (1978): Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2:1457-1459.
34. Pioro EP, Cuello AC (1990): Distribution of nerve growth factor receptor like immunoreactivity in the adult rat central nervous system. Effect of cochicine and correlation with the cholinergic systemII. Brainstem, cerebrellum and spinal cord. Neuroscience 34:89-110.
35. Price DL (1986): New perspectives on Alzheimer's disease. Ann Rev Neurosci 9:489-512.
36. Ray J, Hogg J, Beutler AS, Takayama H, Baird A, Gage FH (1995): Expression of biologically active basic fibroblast growth factor by genetically modified rat primary skin fibroblasts. J Neurochem 64:503-513.
37. Richardson PM, McGuiness UM, Aguayo AJ (1980): Axons from CNS neurons regenerate into PNS grafts. Nature 284:264-265.
38. Rosenberg MB, Friedman T, Robertson RC, Tuszynski M, Wolff JA, Breakefield XO, Gage FH (1988): Grafting genetically modified cells to the brain: Restorative effects of NGF expression. Science 242: 1575-1578.
39. Saffran BN, Woo JE, Mobley WC, Crutcher KA (1989): Intraventricular NGF infusion in the mature rat brain enhances sympathetic innervation of cerebrovascular targets but fails to elicit sympathetic ingrowth. Brain Res 492:245-254.
40. Schnell L, Schneider R, Kolbeck R, Barde Y-A, Schwab ME (1994): Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 367:170-173.
41. Schwab ME (1990): Myelin-associated inhibitors of neurite growth and regeneration in the CNS. TINS 13:452-456.
42. Senut MC, Tuszynski MH, Raymon HK, Suhr ST, Liou NH, Jones KR, Reichardt LF, Gage FH (1995): Regional differences in responsiveness of adult CNS axons to grafts of cells expressing neurotrophin-3. Exp Neurol 135:36-55.
43. Shelton DL, Reichardt LF (1986): Studies on the expression of the beta nerve growth factor (NGF) gene in the central nervous system: Level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons. Proc Nail Acad Sci USA 83:2714-2718.
44. Stromberg I, Wetmore CJ, Ebendal T, Ernfors T, Persson H, Oison L (1990): Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF. J Neurosci Res 25:405-411.
45. Terry RD, Katzman R (1983): Senile dementia of the Alzheimer type. Ann Neurol 14:497-506.
46. Tessler A (1991): Intraspinal transplants. Ann Neurol 29:115-123.
47. Thal LJ (1994): Clinical trials in Alzheimer disease. In Terry RD, Katzman R, Bick KL (eds): Alzheimer Disease. New York: Raven Press, pp 431-444.
48. Tuszynski MH, U H-S, Amaral DG, Gage FH (1990): Nerve growth factor infusions in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci 10:3604-3614.
49. Tuszynski MH, U H-S, Gage FH (1991): Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann Neurol 20:275-281.
50. Tuszynski MH, Senut M-C, Ray J, Roberts J, U H-S, Gage FH (1994a): Somatic gene transfer to the adult primate central nervous system: In vitro and in vivo characterization of cells genetically modified to secrete nerve growth factor. Neurobiol Dis 1:67-78.
51. Tuszynski MH, Peterson DA, Ray J, Baird A, Nakahara Y, Gage FH (1994b): Fibroblasts genetically modified to produce nerve growth factor induce robust neurite ingrowth after grafting to the spinal cord. Exp Neurol 126:1-14.
52. Tuszynski MH, Gage FH (1995): Bridging grafts and transient nerve growth facto infusions promote long term central nervous system neuronal rescue and partial functional recovery. Proc Natl Acad Sci USA 92:4621-4625.
53. Tuszynski MH, Gabriel K, Gage FH, Suhr S, Meyer S, Rosetti A (1996a): Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neuntes after adult spinal cord injury. Exp Neurol 137:157-173.
54. Tuszynski MH, Roberts J, Senut M-C, A, U H-S, Gage FH (1996b): Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically engineered to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther 3:305-314.
55. Widner H, Brundin P (1988): Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Res Rev 13:287-324. ' '
56. Williams LR, Varori S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, Gage FH. (1986): Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci USA 83:9231-9235.
57. Williams LR (1991): Hypophagia is induced by intracerebroventricular infusion of nerve growth factor. Exp Neurol 113:3137.
58. Winkler J, Suhr ST, Gage FH, Thal LJ, Fisher LJ (1995a): Essential role of neocortical acetylcholine in spatial memory. Nature 375:484-487.
59. Winkler J, Ramirez GA, Kühn HG, Peterson DA, Tuszynski MH, Gage FH, Thal LJ (1995b): Induction of Schwann cell hyperplasis in vivo after intracerebroventricular administration of nerve growth factor. Soc Neurosci Abstr 21: 278.
60. Winn SR, Hammang JP, Emmerich DF, Lee A, Palmiter RD, Baetge EE (1994): Polymer encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc Natl Acad Sci USA 91:2324-2328.
61. Wolff JA, Fisher LJ, Xu L, Jinnah HA, Langlais PJ, luvone PM, O'Malley KL, Rosenberg MB, Shimohama S, Friedman T, Gage FH (1989): Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci USA 86:90119014.
62. Xu XM, Guenard V, Kleitman N, Aebischer P, Bunge MB (1995): A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol 134:261-272.